Kabra Drugs
28.50
+0.71(+2.55%)
Market Cap₹67.58 Cr
PE Ratio15.35
IndustryHealthcare
Company Performance:
1D+2.55%
1M-6.71%
6M+68.44%
1Y+157.22%
5Y+564.34%
View Company Insightsright
More news about Kabra Drugs
14Nov 25
Kabra Drugs Limited Reports Profit Turnaround in Q2 FY2026
Kabra Drugs Limited announced financial results for Q2 FY2026, reporting a revenue of ₹1,976.40 lakhs and a net profit of ₹183.68 lakhs. This marks a significant turnaround from the previous quarter's loss. The company's basic earnings per share for the quarter was ₹0.77. The Board of Directors approved these unaudited financial statements on November 13, 2025. The company also disclosed its Board composition and reconstituted various committees as part of its corporate governance practices.
 no imag found
24Sept 25
Kabra Drugs to Finalize Acquisition of AMR Pharma India in Upcoming Board Meeting
Kabra Drugs Limited has scheduled a board meeting for October 8, 2025, to discuss key strategic moves. The agenda includes approving the Share Purchase Agreement for acquiring AMR PHARMA INDIA PRIVATE LIMITED, expanding the board with new technical personnel, and authorizing steps to execute the acquisition transaction. This meeting signals potential growth and enhanced expertise for the pharmaceutical company.
 no imag found
06Aug 25
Kabra Drugs Limited Diversifies into Medical Equipment, Establishes Chennai Office
Kabra Drugs Limited's Board of Directors has approved diversification into the medical equipment and medical instruments sector. The company will establish a new office in Chennai at Cactus Corporate Coworking, Tecci Park, to support this venture. The decision was made during a board meeting on August 6, 2025, from 6:00 PM to 7:00 PM (IST). This move represents a significant expansion of Kabra Drugs' business operations beyond pharmaceuticals.
 no imag found
Kabra Drugs
28.50
+0.71
(+2.55%)
1 Year Returns:+157.22%
Industry Peers
Sun Pharmaceutical
1,714.60
(-0.20%)
Divis Laboratories
5,882.00
(+0.55%)
Torrent Pharmaceuticals
4,029.20
(-0.55%)
Lupin
2,294.10
(-0.18%)
Dr Reddys Laboratories
1,191.40
(-0.39%)
Cipla
1,215.90
(+1.12%)
Zydus Life Science
891.55
(+2.07%)
Mankind Pharma
2,041.90
(+0.09%)
Aurobindo Pharma
1,335.70
(+0.43%)
Alkem Laboratories
5,246.00
(+1.42%)